The impairment of NK cytolytic activity and proliferation under cell–cell contact is partially prevented in the presence of compounds targeting the IDO catabolite kynurenine and PGE2, which are frequently released by tumor cells (Figure 6A,B). Here, IDO1 is linked to neoplasm.